LabGenius
Catherine is responsible for managing scientists within the drug discovery team.
Catherine obtained her undergraduate degree in Chemistry from the University of Oxford, before moving to London to complete her Ph.D. at UCL and working as a PostDoc at Imperial College.
Catherine obtained her undergraduate degree in Chemistry from the University of Oxford, before moving to London to complete her phD at UCL and working as a PostDoc at Imperial College.
Prior to LabGenius, Catherine worked for 10 years at Novartis where she led drug discovery projects from hit identification through to early clinical trials. From there she moved to CRUK where she was Head of Project and Study Management in the Centre for Drug Development.
LabGenius
LabGenius is the first biopharmaceutical company developing next-generation protein therapeutics using a machine learning-driven evolution engine (EVA™).